Amgen holds the cleaner structural position, with the lead spread across growth and profitability. Bayer Aktiengesellschaft still has the edge on growth, which keeps the comparison from looking entirely one-sided. In the market, Bayer Aktiengesellschaft carries the stronger setup — intact trend against Amgen's broken trend. That leaves a split case: the structural lead stays with Amgen, but the market is not currently confirming it.
The comparison is based on similar long-term financial trajectories, not sector labels. Peer scores are normalised within each company's primary universe (AMGN: Nasdaq 100, BAYN.DE: DAX 40).
On growth, the clearer edge sits with Bayer Aktiengesellschaft, while the overall score remains tighter and points the other way.
Both operate in: Drug Manufacturers - General
This comparison is based on industry proximity, not on functional trajectory similarity. AMGN and BAYN.DE share the same industry classification.
For a similarity-based comparison, see how Amgen and Bayer Aktiengesellschaft each position within their functional peer groups in AssetNext.
Scores reflect position relative to comparable companies with similar long-term financial trajectories.
The largest gaps do not all point in the same direction.
Left means cheaper relative valuation. Higher means stronger structure.
Amgen Inc. looks stronger, but the price setup still looks more supportive for Bayer Aktiengesellschaft.
Valuation position uses peer-relative PE percentile (idx_pct_pe) and Forward P/E where available.
Where AMGN and BAYN.DE each sit in their own 5-year price and valuation history.
Describes historical entry positioning only. Descriptive — not investment advice.
One company is still expanding while the other is contracting, which creates a very wide growth split.
On the market side, Bayer Aktiengesellschaft carries the stronger trend while Amgen's trend has broken — the market setup does not confirm the structural advantage.
The lead is built on both growth and profitability — though growth still provides a counterweight.
Break down the AMGN vs BAYN.DE comparison across all dimensions with the full interactive tool.
Explore how AMGN and BAYN.DE each compare against other companies in their peer groups.
Rule-based, descriptive analysis only. Derived from peer percentile dimensions. Not investment advice. Peer groups are determined algorithmically based on structural similarity — not by sector classification alone.
AssetNext scores reflect each company's structural position within its functional peer group — not a ranking against all stocks simultaneously. Peers are identified by similarity across eight financial dimensions, including revenue growth trajectory, margin structure, capital intensity, and earnings stability. A score of 75 means the company ranks in the top quartile within its own peer group, not the entire market.
Four dimension scores drive the overall peer score: Growth (revenue trajectory and expansion dynamics), Quality (margin structure and capital efficiency), Valuation (peer-relative pricing on standard multiples), and Stability (earnings consistency and financial predictability). Each dimension is scored 0–100 relative to the peer group, then combined into an overall peer score using equal weighting.
Because scores are peer-relative, the same company can have slightly different scores in different index universes. On comparison pages, both companies are shown within their shared peer universe wherever possible — so the scores are directly comparable. The peer basis is stated on each score card.
Scores are recalculated periodically as underlying financial data is updated. All analysis is descriptive and rule-based — AssetNext describes structural realities and never issues buy, sell or hold recommendations.